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Abstract 
 
Autophagy has been observed to be a key regulator in myogenesis, maintenance 
of quiescence in satellite cells (SC) and regenerative capacity of skeletal muscle. 
Activator protein-1 (AP-1) transcription factors have been proteins of interest in 
autophagy regulation in various cancers due to the established roles of AP-1 in 
cellular proliferation, death and survival. However, AP-1 involvement in the 
regulation autophagy in skeletal muscle progenitor cells has not been extensively 
assessed.  AP-1 protein c-Jun is expressed in paired box gene 7 (Pax7) positive 
satellite cells.  AP-1 proteins c-Jun and JunB regulate autophagy. Changes to c-
Jun expression lead to changed autophagosome content in C2C12 cells in both 
growth conditions and induced autophagy conditions. Additionally, c-Jun 
knockdown altered autophagosome content in cultures containing Pax7+ and 
Pax7- cells. AP-1 protein c-Jun appeared to be regulated by mTor. AP-1 proteins 
act as autophagy regulators dependent on cell type and autophagy induction 
method.  
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Literature Review 
 
Origin of muscle: from embryogenesis to post-natal development 
 
Each day the majority of our functional movements such as grasping, locomotion and 
even diaphragmatic breathing require the function of skeletal muscles. Skeletal muscle 
is formed during myogenesis and is derived from somites (Buckingham et al. 2003). 
During embryogenic myogenesis, the hypaxial dermomyotome gives rise to the muscles 
of the body and limbs, while the paraxial mesoderm and the prechordal mesoderm give 
rise to the head muscles (Buckingham et al. 2003). The paraxial mesoderm itself arises 
after gastrulation occurs in the blastopore (Chal and Pourquié 2017). Somites are 
formed from the paraxial mesoderm which segments to form the somites during 
somitogenesis (Buckingham et al. 2003; Chal and Pourquié 2017). Segmentation of the 
somites is highly dependent on the morphogen gradients of Wingless/Integrated (Wnt), 
fibroblast growth factor (FGF) and retinoic acid (Bentzinger, Wang, and Rudnicki 2012). 
The somites become compartmentalized to form both a dorsal epithelial dermomyotome 
and a ventral mesenchymal sclerotome (Chal and Pourquié 2017). The ventral 
sclerotome gives rise to skeletal structures while the dermomyotome produces skeletal 
muscle(Chal and Pourquié 2017). Somites then further divide into both lateral and 
dorsal compartments. Hypaxial muscles will be formed from cells located in lateral 
somite while medial cells forms the paraxial muscle (Olivera-Martinez et al. 2000; 
Ordahl and Le Douarin 1992).  
The inhibition of Bone Morphogenetic Protein (BMP) along with the Wnt signaling is 
essential to both dermomyotome specification and maintenance (Hirsinger et al. 1997). 
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The cells of the dermomyotome express Paired box gene 3 (Pax3) Pax3 along with 
Paired box gene 7 (Pax7). Both the hypaxial ventrally located lips and the dorsally 
located epaxial lips of the dermomyotome further mature into the myotome which is the 
primitive muscle structure containing cells which express Myogenic differentiation 1 
(MyoD) and Myogenic factor 5 (Myf5), both which are Myogenic Regulatory Factors 
(MRFs) (Figure 1a)  (Bentzinger, Wang, and Rudnicki 2012). With the expression of 
MyoD and Myf5 initiated in the cells, cells are now committed to the myogenic linage 
and are considered myoblasts.  The maturation of the dermomyotome into the myotome 
is highly dependent on Sonic Hedgehog (Shh) signaling from the notochord and the 
floor plate of the neural tube which causes the upregulation of MRFs, MyoD and Myf5 
along with the downregulation of Pax3 (Bentzinger, Wang, and Rudnicki 2012). Cells 
originating in the dermomyotome expressing Pax3 will also migrate to limb sites and 
further differentiate to form myofibers with an upregulation in expression of both MyoG 
and MCK, marking late differentiation (Bentzinger, Wang, and Rudnicki 2012). 
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Figure 1: Schematic of skeletal muscle formation and differentiation. 
(A) Following somtiogenesis cells of the dermomyotome migrate and mature to form 
the myotome and eventually muscle and eventually committed myogenic linage cells. 
The myogenic cells progress to form myofibers.  (B) The progression of embryonic 
progenitor cells to matured myotubes during muscle differentiation. As myogenic cells 
lose the expression of Pax7 they also lose their stemness and progress into the final 
differentiated state.  (C) Schematic of mature muscle fiber with satellite cell. Images 
adapted from (Bentzinger et al. 2012; Buckingham et al. 2003). 
A 
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The role of Pax3 and Pax7 in Embryonic Myogenesis  
 
Cells migrate from the dermomyotome to form limb muscles due to Pax3 signaling 
(Bentzinger, Wang, and Rudnicki 2012). Pax3 is a paired-homeobox transcription factor 
(Bentzinger, Wang, and Rudnicki 2012). Expression of Pax 3 transcription factor 
induces the transcription of the Tyrosine- protein kinase Met (c-met). C-met interacts 
with scatter factor (SF) and hepatocyte growth factor (HGF), dictating the migratory 
route for the somite derived cells (Buckingham et al. 2003; Dietrich et al. 1999). 
Following migration, the cells migrating from the dermomyotome then express MyoD 
and Myf5 and proliferate in the limb area (Buckingham et al. 2003; Delfini et al. 2005). 
The expression of Myf5 correlates with the downregulation of Pax3 expression (Bober 
et al. 1994; Chal and Pourquine, 2017). With the expression of MyoD and Myf5 initiated 
in the cells, they are now committed to the myogenic linage and are myoblasts.  
Proliferation of these cells in the forming limb has been attributed to signaling through 
fibroblast growth factor (FGF) receptors (Buckingham et al. 2003; Edom-Vovard, 
Bonnin, and Duprez 2001). These myoblasts further mature and differentiate into 
myofibers. Differentiation in the muscle progenitor cells is dependent on the expression 
of Myogenin (MyoG) and Myocyte enhancer factor-2 (Mef2) (Buckingham et al. 2003). 
During the perinatal period, primary and secondary muscle fibers form (Buckingham et 
al. 2003). During the primary phase, myofibers are derived from Pax3 positive cells 
(Horst et al. 2006; Hutcheson et al. 2009; Otto, Schmidt, and Patel 2006). These 
primary fibers are the supporting features for the limb muscles and myotomes which 
myofibers from the secondary phase will be formed upon (Murphy and Kardon 2011).  
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During the secondary phase of myogenesis, a cohort of the Pax3 positive cells begins 
to upregulate Pax7 expression (Chal and Pourquié 2017). The expression of Pax7 
coincides with the downregulation of Pax3 in the myogenic progenitor cells (Chal and 
Pourquié 2017). This secondary phase results in the production of myoblast positive 
with Pax7 expression. Pax7 expression along with Myf5 decreases during early 
differentiation and expression ceases differentiation furthers to myocyte stage 
(Bentzinger, Wang, and Rudnicki 2012). Further differentiation of myocytes into 
myofibers is marked by the expression of MyoD, MyoG as well as Mrf4 (Figure 1b) 
(Bentzinger, Wang, and Rudnicki 2012). The primary phase as well results in the 
establishment of a pool of Pax7 positive progenitor cells (Chal and Pourquié 2017). This 
pool of Pax7 progenitor cells derived from the Pax3 positive population are known as 
satellite cells. The Pax7 expressing satellite cells migrate to lay on the newly 
established myofibers (Yin, Price, and Rudnicki 2013). These cells reside in a specific 
environment, laying on top of the sarcolemma within a continuous layer of basal lamina 
which surrounds the myofiber (Yin, Price, and Rudnicki 2013). These cells maintain a 
quiescent state and are critical for regeneration of muscle in post-natal development 
(Chal and Pourquié 2017; Seale et al. 2000).  
 
Pax7 Positive Cells Are Critical for Post-Natal Injury Response  
 
Following injury, myogenesis in adults is dependent on progenitor cells to produce new 
myofibers on existing muscle fibers (Bentzinger, Wang, and Rudnicki 2012). The 
production of the new progenitor cells is dependent on satellite cells. Pax7 positive 
satellite cells remain in a quiescent state and, upon injury undergo asymmetric 
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proliferation to form cells expressing both Pax7 and MyoD cells that will eventually 
differentiate into new myofibers, losing Pax 7 expression, as well as cells that maintain 
a stem cell pool which will continue to express Pax7 (Cheung and Rando 2013). Cells 
bound for differentiation enter a committed stage in which expression of both Pax7 and 
Myf5 are detected (Bentzinger, Wang, and Rudnicki 2012).   
Following the proliferation of myoblast, Pax7 expression along with Myf5 decrease 
during early differentiation and expression of both Pax7 and Myf5 ceases as 
differentiation furthers to myocyte stage (Bentzinger, Wang, and Rudnicki 2012). 
Further differentiation of myocytes into myofibers is marked by the expression of MyoD, 
MyoG as well as Mrf4 (Bentzinger, Wang, and Rudnicki 2012). Pax7 is a member of the 
homeodomain family transcription factors (Chi and Epstein 2002). The Pax7 gene 
contains three conserved domains: pair domain, octapeptide and a paired-type 
homeodomain, and is a member of the paired-homeobox gene family (Jostes et al., 
1991). Pax7 affects postnatal growth through its regulation of myogenic satellite cell 
specification, modification and maintenance (Olguin et al. 2007; Relaix et al. 2006; 
Seale et al. 2000). In the absence of Pax7 expression, induced through Cre-lox induced 
knock out, hind limb muscles are unable to regenerate following injury (Lepper, 
Partridge, and Fan 2011). It has been observed that Pax7 induction is essential for 
myogenic satellite cell specification in mice (Seale et al. 2000). The Pax7 positive 
satellite cell population undergoes a significant depletion during post-natal development 
from approximately 30% of muscular cells to 2% of muscular nuclei after two months of 
development (Gibson and Schultz 1983). The decline in satellite cells has been linked to 
macroautophagy (García-Prat et al. 2016).  
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Autophagy maintains Homeostasis  
 
Autophagy is a general term to describe the clearing of cytosolic contents from a cell 
(Klionsky 2007). The process itself is characterized by the initiation of a phagophore, 
the elongation of the phagophore to form the double membraned autophagosome and 
the fusion of the mature autophagosome with a lysosome to form the autolysosome 
which degrades its internal contents (Klionsky 2007). Three distinct forms of autophagy 
have been observed, 1) chaperone-mediated autophagy, 2) microautophagy and 3) 
macroautophagy. Macroautophagy (referred to as autophagy for remainder) has been 
observed to play a role in both differentiation of skeletal muscle and the maintenance of 
quiescence in satellite cells and has been studied in both tumor survival and 
neurodegeneration (Fiacco et al. 2016; García-Prat et al. 2016; Rubinsztein 2006; 
Rubinsztein et al. 2007). Autophagy involves the degradation of cytoplasmic 
components including organelles and proteins via delivery of a specialized vacuole to 
lysosomal digestion (Mehrpour et al. 2010). Autophagy is a conserved process in 
eukaryotic cells occurring both in normal conditions and during periods of cellular stress 
(Mehrpour et al. 2010). Autophagy acts in normal conditions to prevent cytotoxicity by 
removing damaged organelles as well as proteins which may aggregate within the cell 
as seen in neurodegeneration (Rubinsztein 2006). However, during stress inducing 
conditions such as nutrient starvation, autophagy plays a role in the recycling of amino 
and fatty acids in order to preserve both adenosine triphosphate (ATP) levels and help 
to restore metabolism, allowing cell survival (Kuma et al. 2004; Mehrpour et al. 2010). 
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Figure 2: Schematic representation of autophagy.  
(A) A schematic of autophagy induction pathways. Autophagy can be inhibited by 
mTOR in its activated state. Rapamycin inhibits mTOR leading to the induction of 
autophagy. Autophagy can also be induced through Beclin-1- a key component in 
the autophagy induction complex. Beclin-1 is inhibited by Bcl-2 and can be 
indirectly activated by JNK through the phosphorylation of Bcl-2 leading to its 
dissociation from Beclin-1. Ras also acts through its downstream target ERK to 
regulate Beclin-1. (B)  A representation of autophagy structures. An initial 
phagophore elongates with the incorporation of LC3 in the cytosol leading to the 
formation of an autophagosome. The autophagosome and its contents are 
degraded upon fusion with a lysosome and formation of an autolysosome. Adapted 
from Mehrpour et al. 2010.  
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Initiation of Autophagy  
 
Autophagy related genes (Atg) have been characterized in yeast, and many have 
mammalian homologs. The initiation of autophagy begins with the autophagosome 
formation (Mehrpour et al. 2010). In yeast, the formation of the autophagosome is 
controlled by an Atg 1: Atg 13: Atg 17 complex (Mehrpour et al. 2010). In mammals the 
initiation complex is composed of the Atg 1 homologs unc-51 like kinase-1 (ULK1) and 
unc-51 like kinase-2 (ULK2), and Atg17 homolog FIP200 which interact with the 
mammalian form of Atg forming the stable ULK:ATG13:FIP200 complex (Hosokawa et 
al. 2009; Mehrpour et al. 2010). The ULK:ATG13:FIP200 complex is stable in basal 
conditions (Mehrpour et al. 2010). The ULK:ATG13:FIP200 complex then interacts with 
Atg 10, which localizes the complex to the phagophore and aids the in stabilization of 
Atg13 expression (Mehrpour et al. 2010). This interaction between the mammalian 
complex and Atg 10 occurs in all conditions – basal and stressed conditions (Mehrpour 
et al. 2010).  
 
Phagophore Formation and Elongation Resulting in Autophagosome 
 
Class III phosphatidylinositol 3-kinase (PI3K), also known as hVps34 complex is critical 
for the assembly of the phagophore. The PI3K complex is composed of III PI3K along 
with p150, Beclin-1 (Itakura et al. 2008). The PI3K phagophore critical complex interacts 
with previously described ULK:ATG13:FIP200 to regulate the beginning of autophagy. 
Following the initiation of the phagophore, the Beclin-1:PI3K:Atg14L complex and other 
Atg proteins recruit a complex composed of Atg proteins Atg12-Atg5:Atg16L as well as 
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microtubule-associated protein 1A/1B light chain 3B protein (LC3) (Mehrpour et al. 
2010). Atg 16L and LC3 have both been shown to be critical for the elongation of the 
phagophore (Lee and Lee 2016; Nakatogawa et al. 2009). During this process, Atg 12 is 
conjugated to Atg5 by Atg10. Along with the conjugation of Atg 12, LC3 undergoes 
transformation through cleavage by Atg4 (Mehrpour et al. 2010). LC3 is cleaved at the 
C terminus resulting in a glycine residue at the start of autophagy (Mehrpour et al. 
2010). The conjugated LC3, known as LC3 II localizes on both the inner and outer 
membranes of the newly formed autophagosome formed at the end of elongation; 
unconjugated LC3 localizes in the cytoplasm (Mehrpour et al. 2010). 
Although non-canonical pathways to autophagosome formation have been discovered, 
they have not been extensively investigated (Mehrpour et al. 2010). These pathways 
occur only with some of the previously described Atg proteins.  
Upon the formation of the autophagosome, the autophagosome can fuse with an 
endosome forming an amphisome, prior to fusion with a lysosome (Seglen et al. 1990; 
Mehrpour et al. 2010). Upon the autophagosome fusion with a lysosome it reaches its 
final stage of maturation forming the autolysosome. The regulation of these fusion steps 
is dependent on various proteins which can either upregulate or downregulate the 
transport of autophagosomes to endosomes and lysosomes (Mephrpour et al. 2010).  
The manipulation of autophagosome trafficking and fusion to a lysosome effects the 
“autophagic flux” of the cell. The Beclin-1 binding protein Rubicon has been observed to 
downregulate the trafficking of the autophagosomes when complexed with Beclin-1, 
PI3K, and UV irradiation resistance-associated gene protein (UVRAG) (Matsunaga et 
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al. 2009). UVRAG has been observed to upregulate the trafficking events of 
autophagosomes (Matsunaga et al. 2009).  
Lysosomal-associated membrane proteins (LAMPs) also play a role in the final stages 
of autophagy. LAMPs are endosome/lysosome transmembrane proteins (Eskelinen, 
Tanaka, and Saftig 2003). In mouse origin fibroblasts, only fibroblasts which are 
deficient for both LAMP-1 and LAMP-2 were observed to have blocked late stage 
autophagy (Tanaka et al. 2000). 
The actual movement of autophagosomes in later stages of autophagy during basal 
conditions is also dependent on the role of microtubules. Through the use of 
nocodazole in mouse hepatocytes, a microtubule destabilizer, a decrease in fusion 
events between autophagosomes and lysosomes has been observed (Bechet et al. 
2005). In instances of starvation, the end stage fusion events required for the formation 
of the autolysosome can be microtubule independent (Fass et al. 2006). In instances of 
starvation, lysosomes can fuse with autophagosomes that are in close proximity (Fass 
et al. 2006).  
 
 
Regulation of Autophagy 
 
The process of autophagy is highly conserved; however, the induction of this process 
can occur through many different pathways. The TOR pathway has been extensively 
studied in both yeast and mammalian models. 
TOR complex 1 (TORC1), in mammalians known as mammalian TOR complex1 
(mTORC) acts to suppress autophagy in non-starvation states (Stokoe et al. 1997). The 
mTORC1, referred to as mTOR for the remainder, is a nutrient signaling pathway in the 
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regulation of autophagy. Rapamycin inhibits  mTOR1, leading to the induction of 
autophagy in non-starvation conditions (Stokoe et al. 1997). It has also been observed 
that mTOR activation can occur through the stimulation of PI3K (He and Klionsky 2009). 
Upon the detection of amino acids, PI3K is stimulated and activates mTOR leading to 
autophagy inhibition. mTOR primary acts as an autophagy inhibitor, only through its 
suppression is mTOR mediated autophagy able to be initiated.   
Growth factors can also inhibit or induce autophagy through the Ras signaling pathway 
(He and Klionsky 2009). Through Ras, growth factor signals are conveyed to class I 
PI3K which inhibits autophagy in mouse embryonic fibroblasts (MEFs) (Furuta et al. 
2004). Growth factors act as ligands for tyrosine kinase receptors and the signal is 
transduced by Ras to class I PI3K (Furuta et al. 2004). However, Ras can also convey 
the growth factor signal from the tyrosine kinase receptor to Raf-1/ Mitogen-activated 
protein kinases (MAPKs) in human colon cancer cells. Raf-1 is a sensor for amino acids 
and leads to the inhibition of autophagy through the downregulation of the downstream 
targets MAPK and extracellular signal-regulated kinases 1/2 (ERK 1/2) (Pattingre, 
Bauvy, and Codogno 2003). This allows for the preservation of proteins in instances of 
amino acid depravation.  ERK promotes autophagy through the regulation of Beclin-1 
protein in cells exposed to X-ray radiation and nutrient starved cells (Kochetkova et al. 
2017; Wang et al. 2009). 
c-Jun N-terminal kinase (JNK) has been observed to regulate autophagy in multiple 
contexts. For example, JNK has been observed as a factor in the regulation of LC3 
lipidation (Ogata et al. 2006). Instances of increases in misfolded proteins causes ER 
stress signals to activate inositol-requiring enzyme 1 (IRE-1), leading to the activation of 
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its downstream target JNK (Ogata et al. 2006). Additionally, JNK has been observed to 
be a post-translational regulator of autophagy. JNK phosphorylates B-cell lymphoma 2 
(Bcl-2), an inhibitor of autophagy in both instances of nutrient starvation and ceramide 
treatment in what cell types (Pattingre et al. 2009). The phosphorylation of Bcl-2 occur 
at Thr69, Ser70 and Ser87 leading to a hyperphosphorylation of the inhibitor which can 
no longer bind to autophagy initiator Beclin-1, allowing Beclin-1 to induce autophagy 
(Pattingre et al. 2009).  
The pathway which induces the initiation of autophagy is highly dependent on the 
stressor and the tissue type. Nutrient signaling, insulin, growth factors, endoplasmic 
reticulum stress, oxidative stress and pathogen infection all can stimulate the induction 
of autophagy through many different mechanisms (He and Klionsky 2009).  
 
 
Autophagy Regulates Myogenesis 
 
Along with autophagy’s role in disease and maintaining homeostasis, autophagy has 
also been shown be a factor in both post-natal myogenesis and regeneration. 
Autophagy maintains the regenerative capacity of satellite cells (García-Prat et al. 
2016). In mouse derived Pax7 positive satellite cells a higher amount of autophagy was 
observed, as well during transplantation experiments, the induction of autophagy in 
geriatric derived satellite cells with lower levels of autophagy helped restore quiescence 
post-transplantation (García-Prat et al. 2016). Reduced autophagic flux in humans is 
also associated with aged patients (García-Prat et al. 2016). The age-related reduction 
in autophagic flux correlates with a regenerative impairment typically seen in later 
stages of adult life. Autophagy as a regulator of satellite cell maintenance of 
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regenerative capacity has also been observed in disease models of Duchenne muscular 
dystrophy (DMD) (Fiacco et al. 2016). In the early stages of DMD, patients are able to 
counter the degenerative effects due to satellite cell mediated regeneration (Collins et 
al. 2005). This enhanced regenerative capacity in DMD has been associated with an 
increase in autophagic flux in DMD models tibialis anterior (TA) muscles compared to 
wild type in the early stages of the disease (Fiacco et al. 2016). During later stages of 
the disease, decreases in the autophagic flux of DMD models and patients is associated 
with reduced regenerative capacity (Fiacco et al. 2016). 
Along with the maintenance of the satellite cell capacity to regenerate, autophagy has 
been seen to play a role in the differentiation. During differentiation of C2C12 myoblasts 
and primary culture myoblasts obtained from mice, levels of autophagy increase ( 
Fortini et al. 2016; McMillian and Quadrilatero 2014). Autophagy induction during the 
differentiation of C2C12 myoblasts is independent of mTORC1 activation (Fortini et al. 
2016). These results indicate that the changes in autophagy activity is required for not 
just the viability of satellite cells but also for normal progression of skeletal progenitors 
into newly formed myofibers. This requirement for autophagy at various levels 
throughout the entire differentiation process shows its critical role for muscle 
regeneration. 
 
 
Activating Protein-1  
 
The activating protein-1 (AP-1) complex is formed by basic region-leucine zipper (bZIP) 
proteins that belong to the Jun, Fos and Maf families (Chimenov and Kerppola 2001). 
The proteins belonging to the Jun family (c-Jun, JunB and JunD) have the ability to form 
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homodimers, however members of the Fos family (c-Fos, Fra-1 and Fra2) do not have 
the ability to form homodimers, but form heterodimers with members of the Jun family 
(Shaulian and Karin 2002). AP-1 dimers composed on Jun and Fos family proteins bind 
to TPA cis element (12-O-tetradecanoylphorbol-13-acetate response element) with the 
sequence 5’- TGAC/GTCA-3’ (Angel and Karin 1991). Although Fos proteins are unable 
to form stable homodimers, upon binding with a member of the Jun family the Fos:Jun 
dimers are more stable than Jun:Jun dimers (Halazonetis et al. 1988). These 
complexes have been observed to be involved in many cellular processes including 
transformation, proliferation, apoptosis and differentiation (Angel and Karin 1991). The 
activity of the AP-1 complex is dependent on the members of the dimer, an example of 
modulating AP-1 complex activity caused by dimer members can be seen in c-Jun. c-
Jun has the highest activation potential of the Jun proteins (Ryseck and Bravo 1991). 
Upon the formation of a heterodimer with c-Fos, the transcriptional activation potential 
further increases due to the stabilization of the dimer (Halazonetis et al. 1988; 
Kouzarides and Ziff 1988). Conversely, the dimerization of c-Jun and JunB weakens the 
transcriptional potential of c-Jun (Chiu, Angel, and Karin 1989; Schütte et al. 1989). In 
human dermal fibroblast the modulation of c-Jun activity through its antagonist JunB 
has been seen as a critical means for the fine balance of cytokine regulation in epithelial 
cells (Szabowski et al. 2000). As well the reduction of c-Jun activity by JunB allows for 
the activation of cyclin D1 promotor in HeLa cells, allowing cells to progress in the cell 
cycle (Bakiri et al. 2000). Along with the modulation of AP-1 protein activity through 
dimerization, the proteins are also modulated through phosphorylation (Karin 1996). 
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Activity of AP-1 proteins is highly diverse 
 
Although the activity of AP-1 complex is highly dependent the dimerization, AP-1 
proteins have individually been associated with specific functions and activation stimuli. 
Jun proteins respond to many different stimuli such as UV irradiation, cytokines, 
oxidative stress and growth factors (Angel and Karin 1991; Angel et al. 1988). 
ERK/MAP kinase (MAPK) cascade causes the induction of fos genes (Karin 1996), 
ERKs directly phosphorylates Fra1 and Fra2 during serum stimulation (Gruda et al. 
1994). Interestingly, the formation of Jun:Fos heterodimers has been shown to also lead 
to an increase in c-Jun gene induction through both monocyte-specific enhancer binding 
factor 2 (MEF2) proteins and various other transcription factors which bind to the c-Jun 
promoter (Han and Prywes 1995). Specifically, MEF2c activation increases c-Jun 
expression (Kato et al. 1997). While c-Jun activity is modulated by phosphorylation by 
JNK, enhancing c-Jun activity (Karin 1996).  
c-Fos and FosB have been seen to participate in cell proliferation regulation. Fibroblasts 
which are deficient for both c-Fos and FosB were observed to have reduced 
proliferative capacity compared to fibroblasts deficient in with c-Fos of FosB (Brown et 
al. 1998). Along with c-Fos and FosB, JunD and c-Jun have been seen to play a role in 
proliferation. In fibroblast, a JunD double knockout in mice correlated with reductions in 
both fibroblast proliferation as well as decreases in fibroblast cell size (Han et al. 1997). 
Knockdowns of c-Jun in fibroblasts have been seen to lead to defects in fibroblasts and 
are unable to maintain prolonged quiescence (Johnson et al. 1993). In fibroblasts which 
have been subjected to UV-irradiation, constant c-Jun expression leads to cells which 
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lack cell cycle control – cells that are unable to stop and continue the cell cycle 
(Shaulian et al. 2000). As well as proliferation, AP-1 proteins play a role in apoptosis. 
Much like the varying roles AP-1 proteins take in proliferation, AP-1 proteins can both 
be proapoptotic and anti-apoptotic depending on both AP-1 protein and cellular 
conditions. Increased levels of c-Jun activity in neuronal cells induces apoptosis in vitro, 
through the regulation of the critical pro-apoptotic Bcl2 family member Bcl-2-like protein 
11 (Bim) (Ham et al. 1995).  
 
AP-1 in Skeletal Muscle Differentiation 
 
Along with AP-1’s role in proliferation and apoptosis, a variety of the proteins play 
critical roles in myogenic cell differentiation. Initial investigations of c-Jun in myogenic 
cells suggested c-Jun inhibited autophagy by dimerizing with MyoD leading to its 
inhibition (Bengal et al. 1992). During the differentiation of C2C12 myoblasts, AP-1 
proteins c-Jun, JunD and Fra2 were observed during the entirety of the differentiation of 
myoblasts into myotubes (Andreucci et al. 2002). Two distinct AP-1 forms of complexes 
were observed during the course of differentiation; complexes of either c-Jun:Fra-2 or 
JunD:Fra-2 heterodimers in differentiating (Andreucci et al. 2002). c-Fos was seen as a 
candidate for the heterodimer partner for AP-1 complexes in C2C12 myoblast in the 
proliferative state due to the high level of c-Fos observed in previous studies (Andreucci 
et al. 2002). c-Fos downregulation by MyoD is required for myogenic cells to progress 
into differentiation (Trouche et al. 1993). Growth factor signaling decreases as cells are 
initiated into differentiation c-Jun expression is seen throughout, which is of particular 
interest as c-Jun transcription was previously observed to be dependent on growth 
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factor signaling (Andreucci et al. 2002). The maintained expression of c-Jun is attributed 
to MEF2 activity in HeLa cells (Andreucci et al. 2002). These AP-1 complexes were 
seen positively correlate with myogenetic differentiation. Fra-2 has also been observed 
to inhibit differentiation when stabilized through phosphorylation by ERK 1/2 (Alli et al. 
2013). In C2C12 reserve cells the loss of Fra-2 expression through siRNA knockdowns 
leads to an increase in myogenic differentiation markers MCK and Myosin Heavy Chain 
(MyHC) (Alli et al. 2013). Fra-2 was observed to be present in C2C12 reserve cells as 
well as mouse isolated satellite cells on myofibers, while being reduced in C2C12 
myotubes (Alli et al. 2013). These findings suggested that Fra-2 played an inhibitory role 
in myogenic differentiation in non-differentiating myogenic cells maintaining a quiescent 
state (Alli et al. 2013). The various roles of AP-1 proteins indicated that AP-1 proteins 
have various effects dependent on both the tissue context, as well as the dimerization 
which results in the complex.  
 
Relationship Between AP-1 and Autophagy 
 
An emerging role for AP-1 complexes has been the regulation of autophagy. AP-1 Jun 
proteins have been investigated in their role of autophagy in cancer cell lines. Jun 
proteins c-Jun and JunB have been shown to be downregulated during nutrient 
starvation induced autophagy in both immortalized and embryogenic derived fibroblasts 
(Yogev et al. 2010). The inactivation of mTOR by Rapamycin positively correlated with a 
decreased level of JunB in HEK293 cells (Yogev et al. 2010). The regulation of JunB at 
the post-transcriptional level occurs in mTOR inhibition autophagy induction through 
Rapamycin treatment, as well as nutrient starvation induced autophagy in HEK293 cells 
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(Yogev et al. 2010). Along with JunB, c-Jun also had an inhibitor effect on nutrient 
starvation induced autophagy in HEK293 cells (Yogev et al. 2010). The inhibitor effect 
of c-Jun on starved HEK293 cells also appears to be JNK activation independent, as c-
Jun with mutated JNK phosphorylation sites inhibit autophagy similar to the wildtype c-
Jun (Yogev et al. 2010). The non-essentiality of c-Jun phosphorylation indicates that the 
involvement of c-Jun can occur without further activity enhancement through JNK, 
alluding to another pathway of activation for autophagy inhibition. However, due to the 
unique nature of AP-1 proteins, and the various roles they can take dependent of 
context, c-Jun has also been associated with the induction of ceramide-mediated 
autophagy in Human Epidermoid carcinoma 3 (Hep3B) cells (Li et al. 2009). In 
response to ceramide treatment, Hep3B cells showed increased levels of JNK activation 
and c-Jun activation which positively correlated with an increase in Beclin-1 and LC3 I/II 
(Li et al. 2009). The correlated increase was further explored in sequence analysis 
revealing a c-Jun binding site within the Beclin-1 promoter, and an increase in c-Jun 
binding to the Beclin-1 promoter region with ceramide treatment in Hep3 cells (Li et al. 
2009). AP-1 protein c-Jun has also been shown to regulate the transcription of LC3 in 
autophagy during ceramide treatment of human nasal carcinoma (CNE2) cells (Sun et 
al. 2011). These results indicate that in ceramide induced autophagy in tumor cells, JNK 
signaling leading to the phosphorylation of c-Jun directly promotes increases in 
transcription of Beclin-1 as well as LC3, increasing autophagy. AP-1 proteins appear to 
play both positive and negative roles in autophagy. The role of AP-1 appears to be both 
dependent on the autophagy induction agent, and its dimer pair.  
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Statement of Purpose 
 
Previous studies have shown that AP-1 proteins play a role in various stages of the 
differentiation of skeletal muscle. The composition of AP-1 complexes change 
throughout differentiation (Andreucci et al. 2002). As well, c-Jun has been observed to 
interact with MyoD to inhibit differentiation (Bengal et al. 1992). Fra-2 has also been 
observed to inhibit differentiation in C2C12 myoblasts in both C2C12 reserve cells and 
SCs (Alli et al. 2013). 
Recent literature has shown that autophagy is a key regulator in the maintenance of 
quiescence in SCs (García-Prat et al. 2016). Autophagy activity has also been seen to 
change throughout stages of differentiation and regulate differentiation in both mouse 
derived primary myoblasts and C2C12 myoblasts (Fortini et al. 2016; McMillan and 
Quadrilatero 2014).  
AP-1 proteins have been implicated in both the promotion and inhibition of autophagy in 
various cancer cell types. Thus, AP-1 proteins may a role in the regulation of autophagy 
in skeletal muscle progenitor cells. To assess the role of AP-1 in autophagy in skeletal 
muscle progenitor cells, this study examined the effects of AP-1 proteins in both basal 
and induced autophagy conditions. It is hypothesized that AP-1 proteins will regulate 
autophagy in skeletal muscle progenitor cells. AP-1 proteins are downstream targets of 
known autophagy regulation pathways (Figure 3). 
Understanding the mechanisms that regulate autophagy in skeletal muscle progenitor 
cells aids in understanding the maintenance of quiescence in SCs and the preservation 
of injury response capabilities in aged individuals and disease models.  
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Figure 3: Proposed relation of AP-1 proteins to autophagy. 
A schematic of autophagy induction pathways. Autophagy can be inhibited by 
mTOR in its activated state. Rapamycin inhibits mTOR leading to the induction of 
autophagy. Autophagy can also be induced through Beclin-1- a key component in 
the autophagy induction complex. Beclin-1 is inhibited by Bcl-2 and can be 
indirectly activated by JNK through the phosphorylation of Bcl-2 leading to its 
dissociation from Beclin-1. Ras also acts through its downstream target ERK to 
regulate Beclin-1. AP-1 proteins are downstream targets of ERK or JNK pathways 
which may contribute to upregulation or downregulation expression of autophagy 
critical components such as Beclin-1.  
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Introduction 
 
Major motor movements, including walking, running, grasping and the ability to maintain 
upright posture is dependent on skeletal muscles. Mature skeletal muscle is the result of 
myogenesis, the process in which skeletal muscle progenitor cells undergo 
differentiation to mature into muscle fibers. During the process of myogenesis, a distinct 
cohort of myoblasts, SCs, continuously express Pax7 and maintain a quiescent state.  
SCs are critical progenitors for post-natal muscle injury repair and regeneration (Lepper, 
Partridge, and Fan 2011). Upon injury, SCs produce myoblasts that further differentiate 
to form new muscle fibers as well as additional SCs to maintain a pool of quiescent cells 
for future injury events (Bentzinger, Wang, and Rudnicki 2012; Buckingham et al. 2003; 
Zammit 2006). SCs have elevated levels of autophagy, which has been demonstrated 
to be critical for the SC’s ability to maintain quiescence (García-Prat et al. 2016). 
Declines in autophagy lead to SCs entering senescence and have been shown in both 
DMD and aged individuals (Fiacco et al. 2016; García-Prat et al. 2016). Decline in 
quiescent SCs are associated with declines in regenerative capacity in the individual. 
Autophagy activity itself changes through the entirety of differentiation, and the changes 
in autophagy are critical for cells’ progression into differentiation (Fortini et al. 2016). 
Autophagy’s critical role in the entire process of muscle differentiation and its 
requirement for maintenance of quiescence of SCs makes it a key component in 
skeletal muscle regeneration.  
Autophagy is a highly conserved cellular process. Autophagy maintains homeostasis 
both in basal conditions and during times of stress; it can be induced by many stimuli 
(Mehrpour et al. 2010). AP-1 proteins are the downstream targets of mTOR 
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independent autophagy pathways.  Both JNK and ERK 1/2 are upstream regulators of 
autophagy and have been seen to induce autophagy in cancer cells in various growth 
conditions and in response to therapeutic agents (Sui et al. 2013).  
AP-1 protein c-Jun is a downstream target of JNK. Downstream phosphorylation of 
JNK, c-Jun, has been detected to both inhibit and promote autophagy in cancer cells. In 
the promotion of autophagy, c-Jun has been observed to bind to Beclin-1 – a critical 
autophagy initiation complex protein- promoter region under ceramide treatment in 
cancer cells (Li et al. 2009). However, in cases of nutrient starvation in cancer cells c-
Jun inhibits starvation induced autophagy (Yogev et al. 2010). In the case on nutrient 
starvation, JunB also suppressed autophagy (Yogev et al. 2010).  
The highly conserved nature of autophagy as well as upstream regulators of AP-1 
proteins have already established roles in cancer cells autophagy regulation, suggesting 
a possible role for AP-1 in autophagy in muscle progenitor cells. AP-1 proteins may a 
role in the regulation of autophagy in skeletal muscle progenitor cells in both basal and 
induced autophagy conditions. In this study we show that AP-1 proteins can act to both 
enhance and supress autophagy in muscle progenitor cells. We show that the effect of 
Jun proteins is dependent on the particular growth conditions of the cells. 
 
 
 
 
 
 
 24 
Material and Methods 
 
Cell Culture 
C2C12 myoblasts were purchased from American Type Culture. Cells were maintained 
in growth media composed of Dulbecco’s modified Eagle’s medium (DMEM) with high 
glucose and L-glutamine (HyClone) supplemented with 10% foetal bovine serum 
(HyClone) and 1% penicillin/streptomycin (Invitrogen). Cells were maintained in a 
humidified 37 °C incubator at 5% CO2 and replenished with fresh medium every 48 
hours.  
Detailed isolation protocol can be found in Appendix. Briefly, primary cultures of skeletal 
muscle were obtained from CD-1 neonatal mice (1-3 days old) using methods described 
by Hindi (2017). Following pre-plating selections as described by Hindi (2017), cells 
were maintained in primary culture growth media containing F-10 media with 20% foetal 
bovine serum (HyClone), 1% penicillin/streptomycin (Invitrogen) and 10ng/mL basic 
fibroblast growth factor (bFGF). Cells were maintained in a humidified 37 °C incubator 
at 5% CO2 and replenished with fresh medium every 48 hours.  
 
Autophagy induction in C2C12 cells 
Detailed protocol can be found in Appendix A. Autophagy induction was accomplished 
using a treatment of 10µg/mL of Rapamycin (sc-3504, Santa Cruz Biotechnology) 
added to C2C12 growth media for 6 hours, or through 6 hour serum starvation in which 
cells were cultured in DMEM with 1% penicillin/streptomycin.  
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Transfection 
Detailed protocol can be found in Appendix A, briefly, C2C12 myoblasts were 
transfected using Polyethyleneimine (PEI). Cells were transfected using a 1:3 DNA (µg) 
to PEI (µg) ratio in C2C12 growth media. A total of 3µg of DNA was used for 6 well 
plates with 9µg PEI. Cells were harvested 48 hours post transfection.  
 
siRNA transfection of C2C12 Myoblasts 
siRNA transfections were performed using calcium precipitation method. Detailed 
protocol can be found in Appendix A. c-Jun siRNAs were used at a concentration of 
100nM. Cells incubated with siRNA calcium precipitation mixture overnight in DMEM. 
Cells were then refreshed with C2C12 growth media. Cells were then harvested 48 
hours post- transfection. 
 
siRNA transfection of Primary Culture 
siRNA transfections were performed using Lipofectamine 2000, siRNAs were used at a 
concentration of 100nM. Detailed protocol can be found in Appendix A. Briefly, prior to 
transfection, cells were refreshed with Primary culture growth media. For a 6-well plate, 
siRNAs were mixed with 4 µg Lipofectamine 2000 in Opi-MEM media. Cells were then 
incubated in 500 µL Opi-MEM and siRNA, Lipofectamine for 4 hours. Primary culture 
growth media was then added to the cells. Cells were harvested 48 hours post 
transfection.  
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Antibodies and reagents  
The following antibodies were purchased from Santa Cruz Biotechnology: actin (sc- 
1616), c-Jun H-79 (sc 1694), JunB, JunD, MyoD. Anti-LC3B (2775), anti-c-Jun 
phosphor-Ser 63 (54B3) were purchased from Cell Signalling. The following siRNAs 
were purchased from Sigma-Aldrich: c-Jun si356 (SASI_Mm01_00046356), c-Jun si357 
(SASI_Mm01_00046357), c-Jun si894 (SASI_Mm02_00318894_AS), Scrambled 
(SIC001). 
 
Immunoblots 
Cells were washed with 1x PBS and lysed in NP-40 lysis buffer (50mM Tris, 150 mM 
NaCl, 0.5% NP-40, 2mM EDTA, 100 mM NaF and 10 mM Na pyrophosphate) 
containing protease inhibitor cocktail (Sigma- Aldrich), 1mM phenylmethylsulfonyl 
fluoride (Sigma- Aldrich) and 1 mM sodium orthovanadate (Bioshop). Protein 
concentrations were determined by Bradford assay (Bio-Rad). Twenty micrograms of 
total protein were resolved to 10% SDS-PAGE and then transferred onto Immobilon-P 
membranes (Millipore) for 1 hour or overnight. Non-specific binding sites were blocked 
using 5% milk in PBS. Membranes were incubated with primary antibodies overnight at 
4°C in 5% milk in PBS or 5% BSA in TBST. Horseradish peroxidase-conjugated 
secondary antibody was added for 2h at room temperature. Protein was detected with 
ECL chemiluminescence reagent (Pierce).  
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Fluorescence Microscopy of Tandem tagged- LC3 positive C2C12 Myoblasts 
Cells were transfected with 1.5ug tandem tagged LC3 plasmid (tLC3) along with 1.5ug 
of c-Jun DNA or control DNA using PEI method. C2C12 myoblasts were fixed using 4% 
paraformaldehyde at room temperature for 5 minutes 48 hours post-transfection. 
Images were acquired using a Zeiss Observer Z1 microscope.  
 
Primary Skeletal Muscle Fiber Isolation and Immunofluorescence Analysis  
Myofibers were isolated from the muscle -extensor digitorum longus (EDL)- of 6-8 week-
old male C57B1/6 mice as previously described by Alli et al. (2013), a detailed protocol 
is described in Appendix. Fibers were fixed in 4% paraformaldehyde in PBS for 5 
minutes and washed three times with PBS. Myofibers were blocked using 10% Horse 
Serum in PBS for 1 hour. Blocking solution was changed, and primary antibodies were 
added to fresh blocking solution. Primary antibodies used were: monoclonal mouse anti-
Pax7 (Developmental Studies Hybridoma Bank) 1:2, c-Jun, JunB (Santa Cruz) 1:500. 
The primary antibodies were incubated overnight with fibers at 4°C. Fibers were then 
washed in PBS three times and incubated with secondary antibodies.  Secondary 
antibodies used:  (1:1000) dilution for 2 hours at room temperature. Nuclei were 
visualized using DAPI counterstain incubation for 30 minutes (1:1000). Myofibers were 
mounted in Fluorescent mounting medium (DAKO cytomation, Cambridgeshire, UK). 
Mounted myofibers were imaged using Zeiss Observer Z1 microscope. 
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Animal Care 
Animals were cared for in accordance with the Institutional Animal Care and Use 
Committee of York University.  
For single fiber experiments, 6- to 8- week old male mice were obtained from Charles 
River. Mice were sacrificed using cervical dislocation in accordance with the Institutional 
Animal Care and Use Committee of York University.  
For primary culture experiments, neonatal mice (1-3 days old) were sacrificed using 
decapitation in accordance with the Institutional Animal Care and Use Committee of 
York University.  
 
Immunofluorescence of Primary Culture  
Primary cultures of skeletal muscle were fixed using 4% paraformaldehyde at room 
temperature for 5 minutes. Cells were permeabilized with 90% methanol in -20 ºC for 6 
minutes. Following permeabilization cells were blocked using 10% goat serum in PBS 
for 30 minutes at room temperature.  0.1% BSA in TBS was then added to cells along 
with primary antibodies. . Primary antibodies used were: monoclonal mouse anti-Pax7 
(Developmental Studies Hybridoma Bank) 1:2, MyoD (Santa Cruz 1:500). Secondary 
antibodies used: FITC and TRITC (1:1000) dilution for 2 hours at room temperature. 
Nuclei were visualized using DAPI counterstain incubation for 30 minutes (1:1000). 
Cells were Images were acquired using a Zeiss Observer Z1 microscope.  
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Statistical Analysis 
Statistical analysis for siRNA knockdown experiments in both C2C12 myoblasts and 
skeletal muscle primary culture conditions was carried out using a non-parametric 
ANOVA Kruskal-Wallis test. The Dunn’s multiple comparisons test was applied with 
comparisons between siRNA groups and control.  Statistical analysis for ectopic 
expression of c-Jun in C2C12 myoblasts with autophagy induction was carried out using 
Mann-Whitney test to compare within groups. Statistical analysis of tLC3 puncta in 
C2C12 myoblasts was carried out using Mann-Whitney test. Non-parametric tests were 
used as data sets failed Anderson-Darling normality test for normal distribution.  
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Results 
 
c-Jun is expressed in satellite cells  
 
Immunostaining for c-Jun was performed on individual skeletal muscle fibers (Figure 4). 
It has been previously shown that AP-1 protein Fra-2 was present in satellite cells (Alli 
et al. 2013).  It was speculated that c-Jun may be visualized in satellite cells as c-Jun is 
a known heterodimer partner to Fra-2 and, shown through protein assays is present in 
myoblasts (Allie et al. 2013).  c-Jun was found expressed in the Pax7 positive cells 
following isolation. c-Jun localization was restricted to Pax7 positive cells and did not 
occur in myofibers nuclei.  These c-Jun and Pax7 positive cells were observed on the 
outer regions of the myofibers, consistent with the localization of satellite cells. Both the 
co-localization of the Pax7 and c-Jun along with location of the positively stained cells 
supported our idea that c-Jun is present in satellite cells.  
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Figure 4: c-Jun localization in satellite cells on myofiber. 
Representative image of a single myofiber was dissected from EDL muscle 
of 6-8-week-old mice. Fibers were immunostained for c-Jun (green) and 
Pax7(red) following fixation. Nuclei were stained with DAPI (blue). Two 
biological replicate experiments were conducted.  
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Endogenous c-Jun reduces LC3II autophagosome content in proliferative 
conditions in C2C12 myoblasts 
 
To observe the effect of endogenous c-Jun on proliferating myoblasts, c-Jun expression 
was reduced using 3 different siRNA in mouse myoblast C2C12 cells. C2C12 myoblasts 
were selected as our experimental model as they express myogenic markers similar to 
human skeletal muscle. C2C12 myoblasts cells also progress into differentiation much 
like human skeletal muscle and in proliferative growth conditions provided a myogenic 
progenitor stable cell line. In the proliferative state, C2C12 myoblasts have 
characteristics of myocytes.  
The cell lysate was subjected to a Western immunoblot. A reduction of c-Jun 
accomplished using three different siRNAs (Figure 5). As shown in Figure 4 the 
reduction of c-Jun led to an increase in overall LC3. To access the changes in 
autophagosome content, we observed the change in the amount of LC3 II in each 
condition. This measurement allowed for the observation of autophagosome content, 
however does not allow to conclusions on changes in autophagic flux. This 
measurement indicates a change occurs in autophagy however conclusion cannot be 
drawn on if this change is an increase or decrease of autophagy or flux. A significant 
increase was noted in LC3 II when compared to controls in one of the three siRNA 
knockdown conditions (Figure 5). Results show that the suppression of endogenous c-
Jun in proliferative conditions caused an increase LC3II content in autophagosomes of 
C2C12 cells. 
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Figure 5: Reduction of endogenous c-Jun leads to an increase in LC3II in 
C2C12 myoblasts.  
 (A) siRNA- mediated knockdown of c-Jun in C2C12 cells. C2C12 cells were 
transfected with three different siRNAs and harvested 48 hours post-
transfection for western blot analysis. SC indicates scrambled siRNA control. 
(B) Densitometric values of LC3 II expression in C2C12 cells following siRNA-
mediated knockdown of c-Jun relative to control. Values normalized to loading 
control. Statistical analysis using a non-parametric Dunn’s multiple comparison 
test; * p= 0.0412. Values quantified using ImageJ (n=2 two biological 
replicates, mean ± s.e.m).  
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Reduction of endogenous c-Jun in primary skeletal muscle culture reduces LC3II 
autophagosome content  
 
To assess the effects of c-Jun on autophagy in primary skeletal muscle cultures c-Jun 
expression was reduced using two different siRNAs which had previously been 
successful in c-Jun knockdown in C2C12 myoblasts (Figure 6). Primary skeletal muscle 
cultures were obtained from CD-1 mouse hindlimb muscles. These cells are unique 
from C2C12 cells as they are in a proliferative state and are myoblasts, a less mature 
state of myogenic progenitors compared to C2C12 cells in proliferative state which are 
characteristically myocytes.  Isolated primary cultures contained myogenetic progenitor 
cells, myoblasts positive for both MyoD and Pax7, as well as myoblasts positive for 
MyoD and lacked Pax7 expression (Figure 6a). Cells positive with only Pax7 were not 
detected. Unlike C2C12 myoblasts, the knockdown of c-Jun lead to a decrease in 
autophagy in primary culture. A reduction was found in overall LC3 expression, as well 
as a decrease in the LC3 II form relative to control (Figure 6b).   
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Figure 6: Reduction of c-Jun in primary skeletal muscle culture decreases 
LC3II autophagosome content. 
(A) Representative image of immunofluorescence of primary culture from neonatal 
mice. Cells were fixed and stained for MyoD (green) and Pax7 (red). Nuclei were 
stained using DAPI. (B) Representative blot of siRNA- mediated knockdown of c-Jun 
in C2C12 cells. C2C12 cells were transfected with two different siRNAs and 
harvested 48 hours post-transfection for western blot analysis. SC indicates 
scrambled siRNA control. (C)  Densitometric values of LC3 II expression in primary 
culture following siRNA-mediated knockdown of c-Jun relative to control. Values 
normalized to loading control. . Statistical analysis using a non-parametric Dunn’s 
multiple comparison test. Values quantified using ImageJ (n=2 biological replicates, 
mean ± s.e.m).  
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Reduction of endogenous c-Jun in C2C12 myoblast has no effect on Rapamycin 
induced autophagy 
 
The opposition effects of c-Jun in primary skeletal muscle cultures and C2C12 
myoblasts alluded to c-Jun having a specific effect dependent on cell type as well as 
possibly autophagy induction mechanism. The specific effects of c-Jun on autophagy 
have been previously shown in the literature in various cancer cell lines. In order to 
further investigate the apparent specificity of c-Jun on autophagosome content in 
skeletal muscle progenitors, c-Jun expression was reduced in C2C12 myoblast using 
siRNAs while inducing autophagy through Rapamycin treatment (Figure 7). 
The reduction of endogenous c-Jun through siRNA knockdown combined with 
autophagy induction due to Rapamycin treatment led to no observable change in the 
observed amount of LC3 II compared to control in observed autophagy in C2C12 
myoblasts. The reduction of c-Jun expression had no apparent effect on Rapamycin 
induced autophagy in C2C12 myoblast when observing changes in autophagosome 
content.   
 
 
 
 
 
 
 
 
 
 
 
 
 37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ectopic expression of c-Jun has unique effects on autophagosome content 
dependent on mode of autophagy induction 
 
A reduction in endogenous c-Jun led to an increase in total LC3 and in LC3 II in C2C12 
cells in basal growth conditions (Figure 5) and had no effect on rapamycin induced 
autophagy (Figure 7). To further evaluate the possibility c-Jun effecting autophagosome 
content in skeletal muscle progenitors, Ectopic expression of c-Jun was induced in 
C2C12 cells to assess its effect on both basal and induced autophagy.  
Figure 7: Reduction of c-Jun has no effect on Rapamycin induced autophagy 
autophagosome content.  
Representative immunoblot of siRNA knockdown of c-Jun in C2C12 myoblasts. 
Cells then were grown in growth media (GM) or treated with Rapamycin (10µg/ml) 
for 6 hours prior to harvest.  C2C12 myoblasts were harvested 48 hours post-
transfection for western blot analysis. Two biological replicates were preformed  
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To observe the effect of ectopic expression of c-Jun on autophagosome content c-Jun 
was overexpressed in growth conditions as well as in two autophagy induction 
conditions, Rapamycin treatment and Serum-Free conditions (Figure 8). Rapamycin 
was used to specifically inhibit mTORC, which leads to the induction of autophagy, 
while serum withdrawal has been shown to induced autophagy (Klionsky et al. 2012). 
Interestingly the ectopic expression of c-Jun in C2C12 myoblasts in growth conditions 
led to an increase in LC3II autophagosome content, shown by a significant increase of 
GFP+RFP+  and RFP+ puncta, and an increase in LC3 II when observed by immunoblot- 
although this result was not significant. When C2C12 myoblasts were treated with 
Rapamycin, there was an increase in c-Jun and JNK activity observed through the JNK 
phosphorylation site Ser63 on c-Jun (Figure 8a). The ectopic expression of c-Jun 
coupled with Rapamycin induced autophagy led to a decrease in LC3II autophagosome 
content relative to the Rapamycin induced state (Figure 8b) . The reduction of LC3II 
content due to c-Jun in instances of induced autophagy seems to specific on condition; 
Serum-Free induction of autophagy was un-effected by ectopic expression of c-Jun.  
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Figure 8: Ectopic expression of c-Jun regulates autophagosome content 
dependent on autophagy induction method in C2C12 myoblasts.   
 (A) Representative blot of ectopic expression of c-Jun in C2C12 myoblasts. Cells then 
were grown in growth media (GM), treated with Rapamycin (10µg/ml) for 6 hours 
(Rapa), or treated with serum free media for 6 hours (-FBS) prior to harvest. C2C12 
myoblasts were harvested 48 hours post-transfection for western blot analysis.  (B) 
Densitometric value of LC3 II expression in C2C12 cells following ectopic expression of 
c-Jun  and treatments. Values quantified using ImageJ (n=2 biological replicates, mean 
± s.e.m). (C) Representative images of ectopic expression of c-Jun in tandem tagged 
LC3 expressing C2C12 cells to monitor autophagy in C2C12 myoblasts in GM. (D) 
Averages of both GFP RFP positive puncta and RFP puncta. Statistical analysis 
carried out using Mann-Whitney * p= 0.0158, ** p=0.025 (A total of 50 cells per 
condition were counted from 2 biological replicates, mean ± s.e.m)  
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AP-1 Proteins have unique effects on induced autophagy in C2C12 myoblasts 
  
AP-1 proteins previously been shown to have unique characteristics on autophagy 
dependent on factors such as cell type and autophagy induction mechanism.  Because 
of AP-1 proteins previously described unique natures, Jun proteins were investigated in 
their effects on autophagy in C2C12 cells. Initial investigations focused on JunB, a 
previously documented repressor of autophagy in (Yogev et al. 2010), as well as JunD. 
The ectopic expression of JunB was successfully achieved in C2C12 myoblasts as 
observed in Figure 9a. The ectopic expression of JunD was not achieved (Figure 9b). 
JunB and JunD were ectopically expressed in C2C12 myoblasts and autophagy was 
induced using both Rapamycin and serum withdrawal. Figure 9 shows that unlike c-Jun 
(Figure 8a), the ectopic expression in growth conditions led to no changes in 
autophagosome content. However, JunB appeared to have a reductive effect on 
Rapamycin induced LC3II autophagosome content in myoblasts (Figure 9). Figure 8 
also shows that unlike c-Jun, neither JunB or JunD expression were increased with 
Rapamycin treatment.  
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A 
Figure 9: Jun proteins reduce induced autophagy. (A) Ectopic 
expression of JunB (A) and JunD (B) in C2C12 myoblasts. Cells then were 
grown in growth media (GM), treated with Rapamycin (10µg/ml) for 6 hours 
(Rapa), or treated with serum free media for 6 hours (-FBS) prior to harvest. 
C2C12 myoblasts were harvested 48 hours post-transfection for western 
blot analysis. Immunoblot represents single measurement.  
 
B 
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Discussion 
 
It has been shown that composition of AP-1 complexes changes throughout 
differentiation, suggesting specific AP-1 components play a role in the regulation of 
differentiation (Andreucci et al. 2002). In particular, c-Jun has been shown to inhibit 
MyoD leading to an inhibition of differentiation (Bengal et al. 1992). As well, AP-1 
protein Fra-2 specifically has been observed to be present in SCs and has been shown 
to inhibit differentiation of myoblasts (Alli et al. 2013). Both c-Jun and Fra2 have been 
observed in myogenic progenitor cells (Alli et al. 2013). AP-1 proteins c-Jun and JunB 
have previously been implicated in the regulation of autophagy in cancer cells (Pattingre 
et al. 2009; Yogev et al. 2010). However, the effect of AP-1 proteins appears to be 
dependent on the method which autophagy is induced as well as cell type (Pattingre et 
al. 2009; Yogev et al. 2010).  
The focus of this study was to examine the regulation of autophagy in skeletal muscle 
progenitor cells by AP-1 proteins. AP-1 proteins are downstream targets of ERK and 
JNK, both which are known upstream regulators of autophagy, and have been of 
interest in autophagy regulation in cancer. 
Recent studies have shown that autophagy is essential for the preservation of 
quiescence in satellite cells and a reduction of autophagy is associated with both age 
and regenerative capacity of skeletal muscle (García-Prat et al. 2016). Autophagy as 
also been shown to be altered in muscle wasting disease DMD. In the early stages of 
DMD, tibialis anterior muscles appear to have greater levels of autophagic flux in 
comparison to non- disease controls, however in later stages autophagic flux decreases 
are observed, becoming equivalent to or less than control levels (Fiacco et al. 2016). 
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The change in autophagy levels corresponds to the muscle wasting severity of the 
disease progression- the early stages autophagy appear to contribute to regenerative 
compensation in DMD (Fiacco et al. 2016). Autophagy contributes to the skeletal 
differentiation process and has been implicated as critical for fusion and differentiation 
(Fortini et al. 2016; McMillan and Quadrilatero 2014).  
As there has been continued exploration of the role of autophagy in various aspects of 
skeletal muscle differentiation and the quiescence of satellite cells, this study aimed to 
explore the regulation of this important process in skeletal muscle progenitor cells.  
This study has shown that c-Jun is present in Pax7 positive satellite cells (Figure 4). 
These results combined with previous findings that c-Jun is expressed in myoblasts (Alli 
et al. 2013), suggest that c-Jun may be important in both processes specific to 
myoblasts and satellite cells. In C2C12 myoblasts, the suppression of endogenous c-
Jun led to an increase of LC3II content in autophagosomes (Figure 5). However, 
reductions of c-Jun in primary culture containing a heterogenous population of 
myogenic progenitors–both Pax7 positive and negative cells– led to a reduction of LC3II 
content in autophagosomes (Figure 6b). The opposing results seen in the reduction of 
c-Jun in C2C12 compared to primary culture conditions could be the result of the cell 
population in the primary conditions. C2C12 myoblasts do not express Pax7 and are 
fully committed showing characteristics of myocytes pre-fusion state. . Primary culture 
as shown in Figure 5a containing a mixed population of committed myoblasts which are 
Pax7-/MyoD+and Pax7+/MyoD+ cells which can be said to be less mature and have the 
characteristic of satellite cells and could potentially have different AP-1 dimer 
complexes. The difference in the basal autophagy functions of myoblasts and satellite 
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cells has been shown in the literature; satellite cells typically have higher autophagy, 
compared to committed myoblasts, and a decline in autophagy is required for initial 
steps of differentiation (Erbay and Chen 2001; Fiacco et al. 2016; McMillian and 
Quadrilatero 2014). As well, the effects of Jun proteins are often highly dependent to 
context, therefore the opposing effects seen in C2C12 cells and primary culture could 
be due to both the differences in basal autophagy levels as well as the distinct cell 
characteristics. Interestingly the ectopic expression of c-Jun in C2C12 myoblasts also 
leads to an increase of LC3II content in autophagosomes in growth conditions (Figures 
8a,c,d). Overall these results indicate that disruption to c-Jun expression leads to 
changes in basal autophagosome content in both C2C12 myoblasts and heterogenous 
populations of myogenic progenitors.  
The ectopic expression of c-Jun in C2C12 myoblasts increased LC3II in 
autophagosome content in growth conditions. This result was contrary to what was 
expected to see, as both a suppression of endogenous c-Jun and ectopic expression of 
c-Jun yielded the same increase of LC3II autophagosome content. The reduction and 
ectopic expression of c-Jun suggests that c-Jun itself may have both a repressive and 
enhancing role in C2C12 myoblasts. The non-linear relationship seen between c-Jun 
expression and autophagy in basal conditions alludes to c-Jun possibly contributing to 
the overall autophagy homeostasis in growth conditions.  
The ectopic expression of c-Jun repressed Rapamycin induced autophagy in C2C12 
myoblasts (Figure 8 a, b). Upon the suppression of endogenous c-Jun in C2C12, 
Rapamycin induced autophagy in myoblasts experienced no alteration in 
autophagosome content (Figure 7). These data suggest that the effect of c-Jun on 
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autophagosome content in myoblasts is dependent on the induction pathway of 
autophagy. The results seen in myoblasts are similar to what has been observed in 
autophagy studies in cancer cell lines (Li et al. 2009; Sui et al. 2013; Yogev et al. 2010).  
Starvation induced autophagy was repressed in HEK293 cells by ectopic expression of 
c-Jun (Yogev et al. 2010). However, in the induction of autophagy by ceramide in 
Hep3b and CNE2 cells, c-Jun is critical for the expression of Beclin-1 and an increase in 
autophagy (Li et al. 2009). These data in conjunction with our results suggest that the 
effect of c-Jun on autophagosome content in myoblasts is dependent on the induction 
pathway of autophagy. We also observed an increase in c-Jun during Rapamycin 
treatment (Figure 8a). 
An increase of c-Jun and c-Jun phosphorylation due to Rapamycin treatment has been 
observed in human rhabdomyosarcoma (Rh30 cells) (Huang et al. 2003). Huang and 
colleagues (2003) detected the effects of JNK activation and Rapamycin induced 
apoptosis. Although Huang et al.’s (2003) study does not explicitly observe autophagy, 
its observations of mTOR activity in conjunction with c-Jun activation show an mTOR 
regulation pathway of c-Jun in Rh30 cells.  The increase in c-Jun activity due to 
Rapamycin treatment in serum free conditions was attributed to the inhibition of mTOR 
(Huang et al. 2003). The increased activity of JNK and, c-Jun expression and 
phosphorylation were shown to be dependent on Rapamycin inhibition of mTOR (Huang 
et al. 2003). Rapamycin treatment lead to sustained activation of JNK without changing 
the overall amount of JNK protein (Huang et al. 2003). The treatment of Rapamycin on 
serum starved Rh30 cells also had no effect on ERK protein levels or activation, 
suggesting the effect of Rapamycin was specific to JNK pathway (Huang et al. 2003). 
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These data in Rh30 cells combined with the results seen in C2C12 myoblasts suggest 
mTOR as a possible area of interest for the regulation of AP-1 protein c-Jun in skeletal 
muscle myoblasts in the future. In particular, Huang and colleagues (2003) found that in 
Rapamycin induced activation of JNK pathway which led to increased activity of c-Jun 
involved 4E-BP1 hypophosphorylation. According to the proposed model pathway, the 
hypophosphorylation leads to the activation of ASK1 and subsequently the sustained 
activation of JNK and increased activity of c-Jun (Huang et al. 2003). 
Hypophosphorylation of 4E-BP1 is characteristic of quiescent cells as it inhibits eIF4E 
which is essential for translation (Gingras et al. 1999). As the hypophosphorylation of 
4E-BP1 is characteristic of quiescent cells, it is a pathway of interest for mTOR 
regulation of c-Jun in quiescent satellite cells.  
The effect of AP-1 proteins on autophagy is unique to both induction mechanism and 
the particular protein AP-1 itself. The ectopic expression of JunB had a unique effect on 
autophagy in comparison to JunB (Figure 9). JunB had no effect on autophagosome 
content in myoblasts in growth conditions unlike c-Jun. Consequently, in growth 
conditions the alteration to autophagosome content is specific to ectopic expression of 
c-Jun  and is not a result of general changes to Jun proteins. JunB did appear to have a 
suppressive effect on LC3II autophagosome content in Rapamycin induced autophagy 
similar to as seen with ectopic expression of c-Jun. The similar effects of c-Jun and 
JunB in the suppressive effect on autophagy in myoblasts is like that seen in HEK293 
cells during starvation conditions (Yogev et al. 2010).  
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When the effect of AP-1 proteins on starvation induced autophagy was tested by Yogev 
and colleges (2010), only c-Jun and JunB were observed to have a suppressive effect 
on starvation induced autophagy. It has been shown in C2C12 myotubes ectopic 
expression of JunB has not had a suppressive effect on autophagy initiation observed 
through LC3 puncta formation during Forkhead Box O3 (FOXO3) ectopic expression; 
FOXO3 initiates autophagy through regulation of Beclin-1 and Bcl-2 Interacting Protein 
3 (Bnip3)- both which are able to initiate autophagy- or starvation (Raffaello et al. 2010). 
JunB ectopic expression was also unable to inhibit FOXO3 mediation autophagy 
progression, marked by the conjugation on LC3 I to LC3 II (Raffaello et al. 2010). JunB 
did appear to partially inhibit the  effect of FOXO3 activation of proteolysis (Raffaello et 
al. 2010). Raffaello and colleagues (2010) concluded that JunB acted independently of 
mTOR myotubes. Our results shown in myoblasts suggest that ectopic expression of 
JunB is similar in growth conditions of myoblasts as myotubes and has no effect on 
autophagosome content, However, in Rapamycin induced autophagy JunB does appear 
to have an effect on autophagosome content in myoblasts.  
Similar to c-Jun, JunB expression did appear to be altered due to Rapamycin treatment 
(Figure 9a). However ectopic expression of JunB appeared enhanced in Rapamycin 
conditions (Figure 9a). The ectopic expression of JunB did have suppressive effects on 
Rapamycin induced autophagy (Figure 8a). In control conditions JunB expression 
appeared to be supressed in Rapamycin treatment compared to growth conditions 
(Figure 9a).  Interestingly JunB has been shown to have no effect on mTOR activity in 
Hek293 cells in either starvation condition and ectopic JunB expression and has been 
shown to act independently of the mTOR pathway in C2C12 myotubes (Raffaello et al. 
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2010; Yogev et al. 2010). In JunB overexpressed HEK293 cells, Rapamycin induced 
autophagy was inhibited, and mTOR downstream target was unaffected, indicating the 
repression of Rapamycin induced autophagy in Hek293 cells by JunB is independent of 
mTOR pathway (Yogev et al. 2010). These findings combined with this study’s 
observation of a repression of JunB in rapamycin induced autophagy in myoblasts 
suggests that JunB may also interact with mTOR in a similar way in C2C12 myoblasts 
as in HEK293 cells. 
 
  
 
 
 
Figure 10: AP-1 protein c-Jun in relation to autophagy induction 
mechanisms. 
A schematic of autophagy induction pathways with inclusion of AP-1 protein 
c-Jun. Autophagy can be inhibited by mTOR in its activated state. Rapamycin 
inhibits mTOR leading to the induction of autophagy. During inactivation of 
mTOR JNK phosphorylation of c-Jun increases. Increased activation of JNK 
during Rapamycin treatment leads to increase of c-Jun activity which 
contributes to changes in autophagosome content; c-Jun contributes to 
changes in autophagy. AP-1 protein c-Jun may have an enhancer effect 
through up regulation of Beclin-1 or perhaps have a suppressive effect on 
Beclin-1 expression. 
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Conclusions and Future Work 
 
AP-1 proteins are a family of transcription factors which are emerging to have roles in 
various processes of skeletal muscle. This study has shown that AP-1 proteins effect 
autophagy in both C2C12 myoblasts and primary myogenic progenitor cells. Both the 
ectopic expression of c-Jun and reduction of endogenous c-Jun in myoblasts in growth 
conditions leads to an increase LC3II in autophagosomes. In a heterogenous population 
of Pax7+ and Pax7- modification of c-Jun expression lead to a decline in autophagy. 
Overall it appears that disruption of normal c-Jun expression alters autophagosome 
content in basal conditions. In C2C12 cells, the relationship between c-Jun and 
autophagosome content to be non-linear as both reduction and ectopic expression yield 
the same increases. The non-linear relationship observed in this study suggests that c-
Jun could perhaps contribute to the overall autophagy homeostasis of the cell.  
 
Ectopic expression of c-Jun repressed Rapamycin induced increase of LC3II in 
myoblasts. JunB expression also repressed Rapamycin induced autophagy in myoblast. 
Ap-1 proteins appear to play a role in the regulation of Rapamycin induced 
autophagosome content changes. The reduction in Rapamycin induced 
autophagosome content changes relates back to the previously stated conclusion that 
c-Jun is perhaps contributing to cellular autophagy homeostasis. High levels of 
autophagy can lead to autophagy mediated cell death, perhaps in conditions where 
autophagy is induced to these potentially cellular lethal levels, c-Jun and JunB act to 
regulate autophagy to maintain homeostatic levels. This regulation of Rapamycin 
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induced autophagy would be an area for future investigation. JunB has been shown to 
have no interaction with mTOR in myotubes (Raffaello et al. 2010) and c-Jun has been 
shown to interact with mTOR in Rh30 cells (Huang et al. 2003), further investigation of 
this interaction in the context of myogenic progenitors. Rapamycin induction of 
autophagy has been used previously in studies to aid in the restoration of regenerative 
capacity of geriatric satellite cells (García-Prat et al. 2016). Understanding of the 
particular mechanisms Rapamycin targets downstream of mTOR in myogenic 
progenitor cells may illustrate a more precise way to regulate autophagy in a cell 
specific manner.  
The findings of c-Jun expression in Pax7+ satellite cells, along with its apparent effects 
on both basal and Rapamycin induced changes in autophagosome content make c-Jun 
a promising candidate for further study. JunB is a protein which warrants further 
investigation in its potential interaction with the mTOR regulation of autophagy which 
was previously explored in myotubes (Huang et al. 2003). JunD would also be of 
interest due to its previously shown presence in myoblast (Andreucci et al. 2002). 
Investigating the regulation by c-Jun of protein expression of autophagy critical factors 
such as LC3, Beclin-1 as well as autophagy inhibiting proteins such as Bcl-2 could shed 
light onto the mechanism by which c-Jun acts to both promote and inhibit autophagy in 
myogenic progenitors. As AP-1 proteins are transcription factors it would be critical to 
find a link between the observed effects and known autophagy relevant genes. Previous 
studies have primarily used ChIP to show c-Jun binding to promoter regions of 
autophagy essential genes such as Beclin-1 and LC3 in cancer cells (Li et al. 2009; Sun 
et al. 2011). It would be beneficial to create a comprehensive list of c-Jun effected 
 51 
genes in myogenetic progenitor cells ¾ both Pax7+ and Pax7- –– cells in basal 
proliferative conditions. As the effect of c-Jun in skeletal muscle appears to be specific 
to basal or induced autophagy similar to what has as seen in cancer cell lines (Li et al. 
2009; Sun et al. 2011). The diverse nature of c-Jun on the regulation of autophagy in 
other tissue types requires a specific RNA sequencing analysis in either basal 
conditions or induced conditions to yield a significant amount of data of c-Jun regulated 
genes. RNA sequencing data of c-Jun knockdown verses c-Jun endogenous expression 
could then be processed through a GO ontology analysis could be performed on 
autophagy related genes –– both initiation and inhibition known genes of autophagy. 
These investigations would provide the critical link between observed effects of c-Jun 
on autophagy and the mechanism by which it regulates both basal and induced 
autophagy. The same experiment could also be carried out on other AP-1 proteins of 
interest, with a focus on the factors which are expressed in both Pax7+ and Pax7- cells.  
Evidence suggests that AP-1 proteins, specifically c-Jun have opposing effects 
dependent of autophagy induction mechanisms. We have shown that c-Jun is an 
interesting candidate for further study in the regulation of autophagy in myogenic 
progenitor cells. Understanding the mechanisms which regulate autophagy in skeletal 
muscle progenitor cells aids in understanding the maintenance of quiescence in satellite 
cells and, the preservation of injury response capabilities in aged individuals and 
disease models.  
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Appendix: Extended Materials and Methods 
 
Primary Skeletal Muscle Isolation and Pre-Plating 
The following protocol is adapted from Hindi et. al 2017. 
 
70% Ethanol 
700mL 100% ethanol 
300mL ddH2O 
 
10% Matrigel 
1. Thaw Matrigel in fridge overnight 
2. Dissolve 10mL cold Matrigel into 90mL cold DMEM 
3. Aliquot 10% Matrigel into tubes and store at -20°C  
 
10% Matrigel Plate 
1. Thaw frozen 10% Matrigel on ice or in fridge overnight 
2. Place plates and pipette tips on ice 
3. Place thawed 10% Matrigel on ice 
4. In Biosafety Cabinet coat plates with Matrigel on ice, remove excess 
5. Place lids on plates and into incubator to dry- Matrigel will solidify when dry 
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Collagenase II 
1.5 U/mL collagenase D (Boehringer Mannheim Corp.) from -20oC frozen aliquot 
2.4 U/mL dispase II (Boehringer Mannheim Corp.) from -20oC frozen aliquot 
2.5 mM CaCl2 added immediately before use 
Combine and use immediately or aliquot and store at -20°C without  
 
F-10-based primary myoblast growth medium (PMGM) 
400 mL Hams F-10 nutrient mixture (GIBCO) 
100 mL fetal calf serum (HyClone) (20% final) 
10ng/mL of basic fibroblast growth factor (human; Promega Corp.) 
5 mL penicillin/streptomycin (1% final) (Invitrogen) 
Store at 4oC  
 
Trypsin 
Dilute Trypsin to 2.5% (v/v) in sterile PBS 
Overall Primary Skeletal Muscle Isolation Protocol  
1. Sacrifice 1-5 CD-1 neonatal mice by approved Animal Care protocol 
2. Rinse limbs with 70% ethanol, remove hindlimb muscles 
3. Place tissue in 10cm plate containing PBS to keep tissue moist 
4. Wash tissue 2X with warm PBS 
5. Aspirate PBS 
6. Add 2mL (adjust volume for additional mice) warmed collagenase II to tissue and 
mince with sterile blades 
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7. Pipette collagenase and tissue mixture into sterile Eppendorf  
8. Incubate mixture at 37 oC for 1 hour (or until mixture appears like a slurry) 
shaking every 10 minutes and vortexing 30 minutes in for 10 seconds 
9. Spin Eppendorf continuing digested tissue for 5 minutes at 350 x g 
10. Carefully aspirate supernatant  
11. Resuspend pellet in 10mL PMGM 
12. Pull mixture up and down in plastic pipette 20-30 times 
13. Place resuspended cells onto 10% Matrigel coated plate- let incubate for at 37 oC 
48-72 hours until cells have settled 
14.  Aspirate media 
15. Add trypsin to plate, place in 37 oC for 3 minutes 
16. Check cells to see if lifted from plate, tap plate on hard surface to remove 
remaining cells- all cells should be dissociated from plate 
17. Add 10mL warmed PMGM to plate, pooling cells 
18. Collect pooled cells and place on uncoated plate 
19. Let incubate for 40-60 minutes- allowing fibroblasts to adhere from plate 
20. Collect media and suspended cells from plate and transfer onto 10% Matrigel 
coated plate 
21. Incubate plate for 24-48 hours and repeat steps 14-20 an additional 2-3 times 
until plate appears to contain mainly small round myoblast cells and only a small 
population of large fibroblast cells 
22. Maintain cells in PMGM and refresh every 48 hours 
 
 65 
Polyethyleneimine Transfection in C2C12 cells 
 
PEI 
Dilute PEI in ddH2O for concentration of 1µg/µL, store at -20 for long term storage. 
1. Day prior to transfection cells were observed to be at 50% confluency in 6-well or 
10cm dish 
2. Refresh cells with fresh growth media 3 hours prior to transfection 
3. Add 200µL room temperature DMEM to 1.5mL Eppendorf tubes  
4. Dilute 3µg/7µg (6 well/10cm plate) of DNA plasmid with 9µg/21µg PEI (6 
well/10cm) in the DMEM Eppendorf tubes 
5. Incubate at room temperature for 20 minutes 
6. Add DNA/PEI complex to cells 
7. Harvest cells 48 hours post-transfection 
 
 
Calcium Phosphate (CaPO4) siRNA Transfection in C2C12 cells  
 
2x HEBES Solution pH 7.15 
16.4g NaCl 
11.9g HEPES 
0.21g NA2HPO4 
700mL ddH2O 
 
2.5M CaCl2 
36.76g CaCl2—2 H2O  
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100ml ddH2O  
 
CaPO4 Overall Protocol 
8. Day prior to transfection cells were observed to be at 40-50% confluency in 6-
well dish 
9. Refresh cells with fresh growth media 3 hours prior to transfection 
10. For each plate being transfected mix together: 100nM siRNA or Scramble 
universal control, 1.25µg dsRed plasmid, 3.75µg pBSK,10µL CaCl2 and sterile 
ddH2O up to 100µL. 
11. Add siRNA-DNA mixture dropwise to 100µL 2XHEBES while vortexing 
12. Incubate mixture for 20-30 minutes at room temperature 
13. Remove 200µL from plates 
14. Add 200µL of transfection mixture to each plate- let transfect for approximately 
16-20 hours 
15. Refresh growth media 
16. Harvest 48 hours post transfection 
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Lipofectamine 2000 Transfection Protocol of Primary Skeletal Muscle 
 
F-10-based primary myoblast growth medium (PMGM) 
400 mL Hams F-10 nutrient mixture (GIBCO) 
100 mL fetal calf serum (HyClone) (20% final) 
10ng/mL of basic fibroblast growth factor (human; Promega Corp.) 
5 mL penicillin/streptomycin (1% final) (Invitrogen) 
Store at 4oC  
Opti-MEM (GIBCO) 
 
Overall Protocol 
 
1. Day prior to transfection cells were observed to be at 40-50% confluency in 6-
well dish 
2. Refresh cells with fresh growth media 3 hours prior to transfection. For each 
plate being transfected mix together: 4µg pcDNA or HA-cJun with 200mL Opti-
mem. In another Eppendorf mix 200mL Opti-mem with 6µL Lipofectamine.  
3. Combine diluted DNA with diluted Lipofectamine and incubate for 5 minutes at 
room temperature. 
4. While DNA:Lipofectamine complex incubates aspirate media from cells and 
refresh with 500mL Opti-mem media warmed to 37 oC 
5. Add DNA:Lipofectamine complex to cells, incubate for 4-6 hours 
6. Add 1.5mL fresh PMGM to cells 
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7. Harvest or fix cells 48 hours post transfection 
 
Western Blot Analysis Protocol  
 
Wash Buffer 
1X TBST- TBS with 0.5% tween20 for antibodies diluted in TBST (Cell signalling 
antibodies and actin) 
 
1XPBST- PBS with 0.5% tween20 for antibodies diluted in PBST (Santa Cruz 
antibodies) 
 
10X Transfer Buffer 
288g glycine 
64.4g Tris base 
1.8L ddH2O 
 
Transfer Buffer 
100mL of 10X transfer buffer 
100mL methanol 
800mL of ddH2O 
 
Blocking Buffer 
150 mL 1X TBST Wash Buffer 
7.5g non-fat powder milk 
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Antibody Dilutions- 5mL 
 
Antibodies were diluted into 1:1000 dilution with final volume of 5mL. Antibodies were 
diluted into either 5% milk in TBST (0.5% tween) or 5% milk in PBST(0.5% tween). 
 
Cell Protein Extracts 
 
 NP40 Lysis Buffer 
 1.25mL of 1M Tris (pH8) 
 0.75mL of 5M NaCl 
 1.25mL of 10%NP-40 
 100µL of 0.5M EDTA 
 5mL of NaF 
 2.5mL of Sodium Pyrophosphate 
Add ddH2O to reach 25mL 
To 2mL of NP-40 Lysis Buffer add: 
20µL of 0.1M Na3VO4 
20µL of 100 mM PMSF 
0.2µL of 10µg/µL Leupeptin  
0.2µL of 10µg/µL Apotinin 
0.5µL of 5µg/µL Pepstatin A 
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1. Remove cells from incubator and place on ice 
2. Aspirate media and wash cells 3x with 5mL cold 1XPBS 
3. Aspirate 1xPBS 
4. Add 1mL 1XPBS to plate 
5. Scrape cells off plate and rinse scraper in ddH2O between plates 
6. Pipette 1mL PBS with plate contents into 1.5mL Eppendorf, place on ice 
7. Spin down at max speed for 15-20 seconds 
8. Discard supernatant 
9. Resuspend pellet in approximately 70µL lysis buffer and protease inhibitor 
combination 
10. Vortex every 10 minutes for 30 seconds (on ice) for a total of 40 minutes 
11. Store in -80°C or use immediately  
 
Sample preparation  
 
Following whole cell lysis and protein extraction protein concentration was 
determined using a Bradford Assay. 
 
1. Samples contain 20ug protein with 3X Lamelli buffer at a (v/v protein) of 50% 
Lamelli buffer 
2. Boil samples for 5 minutes at 95°C  
3. Spin down samples at max speed for 5-10 seconds 
4. Run samples in gel or store at -20°C until ready 
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Western Blot Overall Protocol 
1. Load gels with 5µL ladder and samples 
2. Run gel at 150V in 1X Lamelli buffer for approximately an hour  
3. Following completion of gel run activate membrane in 95% methanol for 5 
minutes 
4. Wet all Waterford paper filters and sponges in 1X transfer buffer 
5. Wash membrane and gel in transfer buffer 
6. Assemble transfer sandwich; black anode plastic, sponge, filter paper, gel, 
membrane, filter paper, sponge, red cathode plastic 
7. Place sandwich in transfer buffer, and place icepack in running tank; run at 100V 
for an hour or 30V overnight in 4°C room 
8. Remove membrane from sandwich and rinse in wash buffer 
9. Block membrane in blocking buffer for 1 hour 
10. Place membrane in container with primary antibody, rock for 1 hour at room 
temperature or overnight at 4°C 
11. Wash membrane 3X for 5 minutes each wash 
12. Place membrane in new container with secondary antibody, rock for 1 hour at 
room temperature 
13. Wash membrane 3X for 5 minutes each wash 
14. Add 500µL of ECL chemiluminescent to membrane, incubate for 1 minute 
15. Remove excess chemiluminescent and put membrane in between plastic sheet 
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16. Place film on top of membrane in dark room 
17.  Waiting time for exposure depends on strength of signal 
18. Fix and develop film 
 
Skeletal Muscle Fiber Isolation 
 
0.2% Collagenase type I  
Dilute Collagenase type I to 0.2% concentration in DMEM. Make 1mL aliquots- 1 aliquot 
can be used per mouse. Store at -20 for extended storage. Warm to 37°C in water-bath 
prior to use. 
 
Isolation Media 
20% FBS in DMEM warmed to 37°C 
 
Culture Media 
DMEM with 20% FBS and 1% Chicken Embryo extract. 
 
Coated Dishes/ Pipettes 
Coat several dishes with 10% Horse Serum (HS) in DMEM 
1. Add 10% HS to dish, swirl around dish and coat sides 
2. Remove excess 
 
Coat large bore pipettes with 10% HS 
1. Pipette 10% HS up and down in glass pipette serval times 
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2. Allow pipette excess HS to run out of pipette by standing in large Eppendorf  
 
Overall protocol (For One Mouse) 
1. Sacrifice 6-8 week old male mouse in accordance to Animal Care protocol 
2. Spray hindlimbs and tools with 70% Ethanol 
3. Dissect back hair and skin from hind limbs. Spray with additional ethanol to 
dampen hair to assist with removal 
4. Remove EDL in one piece by cutting first the distal tendon followed by proximal 
tendon- allows for the least amount of injury 
5. Place muscle into warmed Collagenase solution 
6. Repeat steps 4-5 with other hind limb 
7. Incubate muscle in Collagenase solution for approximately 1 hour, shaking lightly 
every 15 minutes- muscle bundle should seem loosened at end of incubation 
period 
8. Transfer loosened muscle bundle to coated dish containing enough isolation 
media that fibers are moist  
9. Flush muscle with warm media until fibers being to release- this can be done 
under dissection microscope to aid with visualization of dissociated fibers  
10.  Incubate for 30 minutes-1hr in 37°C cell culture incubator 
11.  Remove twisted, coiled dead fibers 
12.  Wash remaining fibers 2X with warmed PBS then aspirate using a 30G needle 
and syringe aids with aspiration  
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13.  Add enough culture media to keep fibers in suspension, incubate for 
approximately 3-4 hours to allow fibers to recover and satellite cells to begin to 
activate 
14. Wash fibers 2X with PBS before fixation and further staining  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
